4,616 Shares of VanEck Pharmaceutical ETF $PPH Bought by Mesirow Financial Investment Management Inc.

Posted by Sarita Garza on Nov 13th, 2026

Mesirow Financial Investment Management Inc. bought a new stake in shares of VanEck Pharmaceutical ETF (NASDAQ:PPH – Free Report) during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund bought 4,616 shares of the company’s stock, valued at approximately $505,000.

Other large investors also recently made changes to their positions in the company. New York Life Investment Management LLC purchased a new stake in shares of VanEck Pharmaceutical ETF in the third quarter worth approximately $2,244,000. Leuthold Group LLC purchased a new position in VanEck Pharmaceutical ETF during the third quarter valued at approximately $711,000. Burke & Herbert Bank & Trust Co. purchased a new position in VanEck Pharmaceutical ETF during the third quarter valued at approximately $423,000. Telos Capital Management Inc. acquired a new position in VanEck Pharmaceutical ETF in the 3rd quarter valued at approximately $608,000. Finally, Commonwealth Equity Services LLC acquired a new position in VanEck Pharmaceutical ETF in the 3rd quarter valued at approximately $1,171,000.

VanEck Pharmaceutical ETF Stock Down 0.3%

PPH stock opened at $121.30 on Friday. VanEck Pharmaceutical ETF has a 12-month low of $97.52 and a 12-month high of $123.53. The company has a market cap of $1.10 billion, a price-to-earnings ratio of 29.81 and a beta of 0.43. The company has a 50 day moving average of $113.51 and a two-hundred day moving average of $108.61.

VanEck Pharmaceutical ETF Cuts Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, October 6th. Stockholders of record on Thursday, October 1st were paid a $0.36 dividend. This represents a $1.44 dividend on an annualized basis and a dividend yield of 1.2%. This is a drop from VanEck Pharmaceutical ETF’s previous quarterly dividend of $0.6248. The ex-dividend date of this dividend was Thursday, October 1st.

VanEck Pharmaceutical ETF Profile

(Free Report)

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.